S02E05 Rebounds are not limited to basketball. Three-Year Clinical Trial of Low-Concentration Atropine for Myopia Progression (LAMP) Study: Continued Versus Washout.

Women in Ophthalmology - 10 Minutes of Science

Content provided by Women in Ophthalmology. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Women in Ophthalmology or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

2y ago 9:10

MP3•Episode home

Rebounds are not limited to basketball. Three-Year Clinical Trial of Low-Concentration Atropine for Myopia Progression (LAMP) Study: Continued Versus Washout.

Rebounds are not limited to basketball. Dr Sarah Hull examines the rebound effect in the Three-Year Clinical Trial of Low-Concentration Atropine for Myopia Progression (LAMP) Study. What are the outcomes of continued atropine treatment, and what is the ideal concentration?

View article here

Sarah Hull is a UK-trained Ophthalmologist who completed a PhD in paediatric retinal genetics at UCL and Moorfields in 2016. She has been living in New Zealand since 2018, working as a consultant Ophthalmologist specialising in paediatrics, strabismus and genetics at Auckland District Health Board and Auckland Eye. She is also a Senior Lecturer at Auckland University. Her research focuses on inherited eye disease as well as optic neuropathies.

20 episodes

#Science #Women In Ophthalmology